Analyst Ratings for Outset Medical
Portfolio Pulse from Benzinga Insights
Outset Medical (NASDAQ:OM) has received mixed analyst ratings in the last quarter, with an average price target of $13.17, which is significantly higher than its current price of $4.2. This target represents a 48.55% decrease from the previous target of $25.60. The ratings include 1 bullish, 2 somewhat bullish, 2 indifferent, and 1 somewhat bearish, with no bearish ratings.
November 14, 2023 | 4:00 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Outset Medical has an average analyst price target of $13.17, which is significantly higher than its current trading price of $4.2, despite a recent decrease in target from $25.60.
The average price target suggests analysts believe the stock has a significant upside potential, which could positively influence investor sentiment and the stock price in the short term. However, the decrease in the target price from $25.60 to $13.17 may reflect some concerns or adjustments in expectations, which could temper the positive impact.
CONFIDENCE 75
IMPORTANCE 80
RELEVANCE 100